A carregar...
A Randomized Noninferiority Trial of Intravenous Iron Isomaltoside versus Oral Iron Sulfate in Patients with Nonmyeloid Malignancies and Anemia Receiving Chemotherapy: The PROFOUND Trial
STUDY OBJECTIVE: A safe alternative to erythropoiesis‐stimulating agents to treat anemia is warranted in patients with cancer and anemia; thus the objective of this trial was to compare the efficacy and safety of intravenous (IV) iron isomaltoside with oral iron in patients with cancer and anemia by...
Na minha lista:
Publicado no: | Pharmacotherapy |
---|---|
Main Authors: | , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
John Wiley and Sons Inc.
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5071650/ https://ncbi.nlm.nih.gov/pubmed/26927900 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/phar.1729 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|